Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2019
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic CancerKyle C Cuneo, Meredith A Morgan, Vaibhav Sahai, et al.
Molecular Cancer Research : MCR|March 29, 2022
DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic CancerWeiwei Wang, Matthew T McMillan, Xinyi Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2013
Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776Carl G Engelke, Leslie A Parsels, Yushen Qian, et al.
Cancer Research|May 27, 2010
Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repairMeredith A Morgan, Leslie A Parsels, Lili Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2011
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibitionLeslie A Parsels, Yushen Qian, Daria M Tanska, et al.
Cancer Research|May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade TherapyQiang Zhang, Michael D Green, Xueting Lang, et al.
JCI Insight|February 20, 2024
Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancerQiang Zhang, Long Jiang, Weiwei Wang, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Neuro-Oncology|April 10, 2025
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibitionYupei Guo, Zian Li, Leslie A Parsels, et al.
Molecular Cancer Therapeutics|July 14, 2026
H3K27M enhances basal ATM signaling but is not required for radiosensitization of diffuse midline glioma via ATM inhibition with AZD1390Erik R Peterson, Leslie A Parsels, Zian Li, et al.
Pageof 4